Results 151 to 160 of about 131,069 (291)
SLC7A6OS Founder Mutation: A Rare Cause of Progressive Myoclonus Epilepsy Dated to 1100 Years Ago
Abstract Background SLC7A6OS c.191A>G is a rare, autosomal recessive cause of progressive myoclonus epilepsy (PME). The c.191A>G variant, first discovered in two families from Türkiye and Portugal, was recently identified in three additional probands from the USA, all of Puerto Rican ancestry.
Bronwyn E. Grinton +17 more
wiley +1 more source
Immediate Effect of Sensory Level Stimulation on Spasticity in Patients with Post-stroke Hemiplegia
Background: Spasticity is one of the impairments in patients with stroke which cause more disability and secondary problems. Now, there are some ways to reduce spasticity such as drugs, exercise, heat, massage, and sensory level electrical stimulation ...
Mahdi Afshar-Safavi +2 more
doaj
Acute Post‐Partum Psychosis and Dystonia Reveals Late‐Onset MPAN
Movement Disorders Clinical Practice, EarlyView.
Mathilde Lachaume +7 more
wiley +1 more source
GCH1 p.Ser80Asn Confers Risk for Parkinson's Disease in East Asian Populations
Abstract Introduction GCH1 has been implicated in Parkinson's disease (PD), but its risks variants and associations are not well defined. Objectives Our goal was to investigate the clinical relevance and PD risk associated with the GCH1 p.Ser80Asn variant.
Yi Wen Tay +37 more
wiley +1 more source
Abstract Background Association between monoallelic STUB1 variant and expanded ATXN8OS alleles was recently reported, suggesting a pathogenic interaction that may influence spinocerebellar ataxia type 48 (SCA48) phenotype. Objectives We investigated the frequency and clinical impact of ATXN8OS in a large cohort of STUB1 carriers compared to individuals
Charlotte Mouraux +11 more
wiley +1 more source
Abstract Background Molecular testing for genetic movement disorders (MDs) increasingly relies on exome‐ or genome‐based virtual gene panels. In the absence of consensus guidelines, MD panel design remains heterogeneous across laboratories, with international variation in panel configuration and gene content.
Teodora Barbarii +8 more
wiley +1 more source
Physical therapy modalities used in spasticity treatment
Spasticity is a motor disorder characterized by an increase in velocity-dependent tonic stretching reflexes, along with increased tendon leaps resulting from the hyperexcitability of stretching reflexes. The primary goal of spasticity treatment should be
Şahin, Nilay, Yeşil, Hilal
core
ABSTRACT Aims To assess 1‐year Transcutaneous Tibial Nerve Stimulation (TTNS) treatment persistence in routine clinical care and to explore clinical and urodynamic factors associated with treatment persistence in patients with lower urinary tract dysfunction (LUTD).
Damien Prat +9 more
wiley +1 more source
ABSTRACT Background MECP2‐related disorders encompass a broad spectrum of movement disorders, but opsoclonus has not been characterized within this spectrum. Case Presentation We describe a girl with a de novo pathogenic MECP2 variant who developed an acute/subacute cerebellar presentation following a prolonged febrile illness, evolving from prominent ...
Bruno Antunes Contrucci +7 more
wiley +1 more source

